The FDA is now debating whether or not new and existing drugs should go through further testing to determine cardio risks. Pegloticase-based on 12 mo treatment data- has shown no adverse links to cardiovascular disease. In fact, recent large studies have shown that gout is the 3rd biggest risk factor to heart attacks. Lowering uric acid levels rapidly and eliminating gout may greatly ...


